Log in
NASDAQ:MMSI

Merit Medical Systems Stock Forecast, Price & News

$42.19
-0.26 (-0.61 %)
(As of 09/18/2020 10:42 PM ET)
Add
Compare
Today's Range
$41.77
Now: $42.19
$43.66
50-Day Range
$42.37
MA: $46.63
$49.82
52-Week Range
$19.50
Now: $42.19
$50.38
Volume2.16 million shs
Average Volume526,493 shs
Market Capitalization$2.34 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.05
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions. The company also offers cardiovascular and critical care products to treat patients with life-threatening diseases, protect healthcare providers from exposure to bloodborne pathogens, and provide medical devices. In addition, it provides interventional oncology and spine products comprising delivery system, embolotherapy, spine ablation, and vertebral compression fracture products to treat metastatic spinal tumors, liver cancer, uterine fibroids, benign prostatic hyperplasia, vertebral compression fractures, and arteriovenous malformations and hemostatic embolization, as well as breast cancer localization and guidance products for the treatment of breast cancer. Further, the company offers non-vascular stents to treat pulmonary and gastrointestinal diseases; dilation balloons to endoscopically dilate strictures; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical system sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
Read More
Merit Medical Systems logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.04 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:MMSI
CUSIP58988910
Phone801-253-1600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$994.85 million
Cash Flow$3.29 per share
Book Value$17.21 per share

Profitability

Net Income$5.45 million

Miscellaneous

Employees6,355
Market Cap$2.34 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$42.19
-0.26 (-0.61 %)
(As of 09/18/2020 10:42 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MMSI News and Ratings via Email

Sign-up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions

How has Merit Medical Systems' stock price been impacted by COVID-19?

Merit Medical Systems' stock was trading at $32.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MMSI stock has increased by 28.3% and is now trading at $42.19.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Merit Medical Systems?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 sell rating, 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Merit Medical Systems
.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Merit Medical Systems
.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) released its quarterly earnings results on Wednesday, July, 29th. The medical instruments supplier reported $0.31 EPS for the quarter, beating the consensus estimate of $0.07 by $0.24. The medical instruments supplier had revenue of $218.37 million for the quarter, compared to the consensus estimate of $192.67 million. Merit Medical Systems had a negative net margin of 3.10% and a positive return on equity of 8.10%. The business's revenue for the quarter was down 14.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.42 earnings per share.
View Merit Medical Systems' earnings history
.

What price target have analysts set for MMSI?

9 analysts have issued 1 year price targets for Merit Medical Systems' shares. Their forecasts range from $30.00 to $63.00. On average, they expect Merit Medical Systems' stock price to reach $47.13 in the next year. This suggests a possible upside of 11.7% from the stock's current price.
View analysts' price targets for Merit Medical Systems
.

Are investors shorting Merit Medical Systems?

Merit Medical Systems saw a decrease in short interest in the month of August. As of August 14th, there was short interest totaling 3,560,000 shares, a decrease of 13.4% from the July 30th total of 4,110,000 shares. Based on an average daily trading volume, of 408,300 shares, the days-to-cover ratio is currently 8.7 days. Currently, 6.6% of the company's stock are short sold.
View Merit Medical Systems' Short Interest
.

Who are some of Merit Medical Systems' key competitors?

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), Exfo (EXFO), Energy Transfer LP Unit (ET), RTI Surgical (RTIX), Under Armour (UA), Neurometrix (NURO) and NVIDIA (NVDA).

Who are Merit Medical Systems' key executives?

Merit Medical Systems' management team includes the following people:
  • Mr. Fred P. Lampropoulos, Chairman, CEO & Pres (Age 69)
  • Mr. Ronald A. Frost, Chief Operating Officer (Age 57)
  • Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 58)
  • Mr. Joseph C. Wright, Pres of International Division (Age 49)
  • Mr. Raul Parra Jr., CPA, CFO & Treasurer

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.31%), ArrowMark Colorado Holdings LLC (8.40%), Nuance Investments LLC (5.68%), Conestoga Capital Advisors LLC (3.55%), Macquarie Group Ltd. (3.35%) and William Blair Investment Management LLC (1.74%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, David Floyd, David Ming-Teh Liu, Enterprise Associates 14 New, F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Raul Jr Parra and Ronald Frost.
View institutional ownership trends for Merit Medical Systems
.

Which major investors are selling Merit Medical Systems stock?

MMSI stock was sold by a variety of institutional investors in the last quarter, including Nuance Investments LLC, ArrowMark Colorado Holdings LLC, FMR LLC, Frontier Capital Management Co. LLC, Emerald Advisers LLC, Barclays PLC, Emerald Mutual Fund Advisers Trust, and BRYN MAWR TRUST Co. Company insiders that have sold Merit Medical Systems company stock in the last year include A Scott Anderson, David Ming-Teh Liu, Franklin J Miller, Fred P Lampropoulos, and Nolan E Karras.
View insider buying and selling activity for Merit Medical Systems
.

Which major investors are buying Merit Medical Systems stock?

MMSI stock was purchased by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Goldman Sachs Group Inc., Point72 Asset Management L.P., Jacobs Levy Equity Management Inc., Glenmede Trust Co. NA, Macquarie Group Ltd., Man Group plc, and Russell Investments Group Ltd.. Company insiders that have bought Merit Medical Systems stock in the last two years include David Floyd, Enterprise Associates 14 New, Raul Jr Parra, and Ronald Frost.
View insider buying and selling activity for Merit Medical Systems
.

How do I buy shares of Merit Medical Systems?

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $42.19.

How big of a company is Merit Medical Systems?

Merit Medical Systems has a market capitalization of $2.34 billion and generates $994.85 million in revenue each year. The medical instruments supplier earns $5.45 million in net income (profit) each year or $1.46 on an earnings per share basis. Merit Medical Systems employs 6,355 workers across the globe.

What is Merit Medical Systems' official website?

The official website for Merit Medical Systems is www.merit.com.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.